SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs strong quarterly results and raised outlook have been overshadowed by a sharp post-earnings selloff, with traders focused on slowing contract-value bookings and the high valuation. Bulls see accelerating commercial AI demand as intact and view the decline as a buying opportunity, while bears question whether growth can justify the premium.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells announced all-stock acquisition of Lumentum is driving debate, with traders focused on dilution, deal timing, and execution risks as the stock sells off and analyst downgrades add pressure. Some see the deal as a strategic way to expand in AI optical connectivity and are buying the dip, but skepticism about the terms and near-term outlook dominates.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A record fiscal-quarter report, stronger bookings and a raised fiscal-year revenue outlook tied to AI-chip testing demand are driving AEHRs sharp rebound. Traders are broadly upbeat about the results and growth prospects, while others caution that the stocks valuation and volatile post-earnings move could limit gains.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys quarterly results and outlook have driven a sharp selloff: traders focus on revenue and GMV missing expectations and growth moderating, despite an earnings beat and strong cash generation. The community is split between calling the drop an overreaction and buying the dip, and arguing that high valuation leaves little room for slower growth or AI-related competition.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the following business segments: Cannabis and Plant Propagation. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Reports that Organigram agreed to acquire Aurora, topping Curaleafs competing bid, are driving the attention. Traders are reacting to the takeover premium, while debating whether the terms are fair and whether Curaleaf or another bidder could still make a stronger offer.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiservs quarterly results beat estimates, with full-year guidance reaffirmed and stronger cost-savings and share-repurchase plans helping drive a sharp rebound after a prolonged decline. Bulls see signs of a turnaround under new management, while skeptics question whether the improvement can last; short-squeeze claims remain speculation.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigals quarterly results put its first profitable quarter and continued Rezdiffra growth at the center of discussion. Traders are split between viewing the launch as strong and questioning spending, sales quality, and the stocks fade despite the positive results.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is drawing attention after a strong quarterly earnings beat, raised full-year guidance and a record backlog, with traders highlighting a technical breakout and bullish call activity. Some remain cautious, pointing to the stocks subdued reaction to strong results and recent weakness across defense shares.

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Organigrams agreement to acquire Aurora has displaced Curaleafs rival bid, prompting debate over whether Curaleaf will keep pursuing Aurora or move on to other acquisition opportunities. Some traders view losing the bid as avoiding a costly deal, while others speculate the takeover contest could continue.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples earnings beat was overshadowed by a weaker holiday-quarter margin outlook as rising memory costs and AI-related expenses pressure profitability. Traders are split between expecting further selling over margin and valuation concerns and viewing the drop as a buying opportunity given strong iPhone demand and the companys earnings performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ICU Sitting at a mere 10M Market Cap, Seastar (ICU) will generate more revenue than that in 2027 with today&#39;s removal of the registry requirement. 
7 BDDs, with the most recent for Sepsis as a standalone indication.   
TAM easily in the billions once adult use approved in early/mid-2027. 
Pediatric already approved under HDE. 
Incredibly underpriced.  
Related biotechs that supply tubing, equipment, and medicines for Sepsis, AKI, cancer, and heart disease could also be affected. 
https://investors.seastarmedical.com/news-releases/news-release-details/fda-confirms-seastar-medical-has-fulfilled-post-approval-study 
$BAX $MCK $JNJ $MRNA

BioSwings™

Carl-Johan Lilja

Romorton

Dennis Loser

DENVER, Nov. 03, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today the Center for Biologics Evaluation

SeaStar Medical

FDA Confirms SeaStar Medical Has Fulfilled the Post-Approval Study Requirements for QUELIMMUNE® for the Treatment of Sepsis-Associated Acute Kidney Injury (AKI) in Pediatric Patients - Tue, 11/03/2026 - 08:21

$ICU $BAX $MCK $JNJ $MRNA so how can you explain there are no investors? Bleeding everyday since big announcemnt on important conference?  
 
All those guys who are rich AF   , doctors, people from pharma business etc. They have plenty of money, they know the „news” and understand the potential of medical devices better than anyone. Why they dont give a f** about this company ???

StockTwits Web

Netlinetli

SeaStar Medical Holding Corp

Baxter International Inc.

Mckesson Corporation

Johnson & Johnson

Moderna Inc

 Sitting at a mere 10M Market Cap, Seastar (ICU) will generate more revenue than that in 2027 with today's removal of the registry requirement. 
7 BDDs, with the most recent for Sepsis as a standalone indication.   
TAM easily in the billions once adult use approved in early/mid-2027. 
Pediatric already approved under HDE. 
Incredibly underpriced.  
Related biotechs that supply tubing, equipment, and medicines for Sepsis, AKI, cancer, and heart disease could also be affected. 
